CorMedix Appoints Greg Duncan to its Board of Directors
November 02, 2020 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Nov. 02, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix Inc. to Report Third Quarter 2020 Financial Results and Provide a Corporate Update on November 5
October 29, 2020 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Oct. 29, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix to Participate in BIO Investor Forum Digital
October 08, 2020 09:00 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Oct. 08, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix Appoints Paulo Costa to its Board of Directors
September 17, 2020 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Sept. 17, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference
September 09, 2020 08:30 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Sept. 09, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix Inc. Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Defencath
August 31, 2020 07:47 ET
|
CorMedix, Inc.
FDA sets PDUFA goal date of February 28, 2021Potentially the first antibacterial and antifungal catheter lock solution in the US to prevent catheter related infections in hemodialysis patients ...
CorMedix Inc. Reports Second Quarter and Six Month 2020 Financial Results and Provides Business Update
August 10, 2020 16:05 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Aug. 10, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix Inc. to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 10
August 03, 2020 16:05 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., Aug. 03, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the...
CorMedix Announces Pricing of $20M Public Offering of Common Stock
July 28, 2020 09:21 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD) (the “Company”), a biopharmaceutical company focused on developing and commercializing therapeutic...
CorMedix Announces Proposed Public Offering of Common Stock
July 27, 2020 16:05 ET
|
CorMedix, Inc.
BERKELEY HEIGHTS, N.J., July 27, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD) (the “Company”), a biopharmaceutical company focused on developing and commercializing therapeutic...